{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:24:02Z","timestamp":1740165842880,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s13730-018-0303-8","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T10:33:05Z","timestamp":1516271585000},"page":"98-100","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Membranous glomerulonephritis with an LMNA mutation"],"prefix":"10.1007","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7556-4714","authenticated-orcid":false,"given":"Kumi","family":"Fujita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Hatta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"303_CR1","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1152\/physrev.00047.2005","volume":"86","author":"JLV Broers","year":"2006","unstructured":"Broers JLV, Ramaekers FCS, Bonne G, Yaou RB, Hutchison AC. Nuclear lamins: laminopathies and their role in premature ageing. Physiol Rev. 2006;86:967\u20131008.","journal-title":"Physiol Rev"},{"key":"303_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1440-1827.2008.02286.x","volume":"58","author":"T Kimura","year":"2008","unstructured":"Kimura T, Kuramochi S, Katayama T, Hoshikawa T, Yamada T, Ueda Y, Okada Y. Amiodarone-related pulmonary mass and unique membranous glomerulonephritis in a patient with valvular heart disease: diagnostic pitfall and new findings. Pathol Int. 2008;58:657\u201363.","journal-title":"Pathol Int"},{"key":"303_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","volume":"361","author":"LH Beck","year":"2009","unstructured":"Beck LH, Bonegio RGB, Lambeau G, Beck DM, Powell DW, Cummins TD, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med. 2009;361:11\u201321.","journal-title":"N Engl J Med"},{"key":"303_CR4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1009742","volume":"364","author":"HC Stanescu","year":"2011","unstructured":"Stanescu HC, Arcos-Burgos M, Mediar A, Bockenhauer D, Kottgen A, Dragomirescu L, et al. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy. N Engl J Med. 2011;364:616\u201326.","journal-title":"N Engl J Med"},{"key":"303_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S0190-9622(87)80062-2","volume":"16","author":"S Chartier","year":"1987","unstructured":"Chartier S, Buzzanga JB, Paquin F. Parial lipodystrophy associated with a type 3 form of membranoproliferative glomerulonephritis. J Am Acad Dermatol. 1987;16:201\u20135.","journal-title":"J Am Acad Dermatol"},{"key":"303_CR6","doi-asserted-by":"publisher","first-page":"c35-c38","DOI":"10.1159\/000076396","volume":"96","author":"KR Owen","year":"2004","unstructured":"Owen KR, Donohoe M, Ellard S, Clarke TJ, Nicholls AJ, Hattersley AT, Bingham C. Mesangiocapillary glomerulonephritis type 2 associated with familial partial lipodystrophy (Dunnigan-Kobberling syndrome). Nephron Clin pract. 2004;96:c35-c38.","journal-title":"Nephron Clin pract"},{"key":"303_CR7","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(73)92351-9","volume":"2","author":"DK Peters","year":"1973","unstructured":"Peters DK, Charlesworth JA, Sissons JG, Williams DG, Boulton-Jones JM, Evasn DJ, et al. Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia. Lancet. 1973;2:535\u20138.","journal-title":"Lancet"},{"key":"303_CR8","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1210\/jc.2003-032140","volume":"89","author":"ED Javor","year":"2004","unstructured":"Javor ED, Moran SA, Young JR, Cochran EK, Depaoli AM, Oral EA, et al. Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: base line characteristics and course during recombinant leptin therapy. J Clin Endocrinol Metab. 2004;89:3199\u2013207.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-018-0303-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-018-0303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-018-0303-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T19:52:14Z","timestamp":1547754734000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-018-0303-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["303"],"URL":"https:\/\/doi.org\/10.1007\/s13730-018-0303-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"type":"electronic","value":"2192-4449"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"8 June 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors have declared that no conflict of interest exists.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal rights"}},{"value":"Informed consent was obtained from the patient for being included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}